Clinical Trials Search
Clinical Trial 19719
Cancer Type: Malignant Hematology
Interventions:748645 (Ibrutinib); Ibrutinib (Imbruvica); PCI-32765 (Ibrutinib); Tisagenlecleucel ()
Study Type: Treatment
Phase of Study: Phase I
Investigators:
- Julio Chavez
Study Title
A Phase Ib, Multicenter Study To Determine The Safety And Tolerability of Tisagenlecleucel in Combination with Ibrutinib in Adult Patients With Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma
Summary
Objective
The primary objective of this study is to assess the safety and tolerability of tisagenlecleucel in combination with ibrutinib